MENU
ONC
AS OF
Feb 4, 03:44 PM (EDT)
Price
$349.63
Change
+$3.25 (+0.94%)
Capitalization
39.4B
70 days until earnings call
Intraday BUY SELL Signals
+Compare
ONC
Stock ticker: NASDAQ
AS OF
Feb 4, 03:44 PM (EDT)
Price
$349.63
Change
+$3.25 (+0.94%)
Capitalization
39.4B

ONC BeOne Medicines Ltd Forecast, Technical & Fundamental Analysis

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales... Show more

Industry: #Biotechnology
ONC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ONC with price predictions
Feb 03, 2026

Momentum Indicator for ONC turns positive, indicating new upward trend

ONC saw its Momentum Indicator move above the 0 level on January 29, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ONC just turned positive on January 05, 2026. Looking at past instances where ONC's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

ONC moved above its 50-day moving average on January 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ONC crossed bullishly above the 50-day moving average on January 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ONC advanced for three days, in of 301 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 211 cases where ONC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where ONC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ONC broke above its upper Bollinger Band on January 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ONC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.285) is normal, around the industry mean (27.519). ONC's P/E Ratio (666.115) is considerably higher than the industry average of (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (7.752) is also within normal values, averaging (331.843).

View a ticker or compare two or three
ONC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ONC is expected to report earnings to fall 42.26% to $1.53 per share on April 15

BeOne Medicines Ltd ONC Stock Earnings Reports
Q4'25
Est.
$1.53
Q3'25
Beat
by $1.85
Q2'25
Missed
by $0.04
Q1'25
Beat
by $1.65
Q4'24
Missed
by $0.42
The last earnings report on November 06 showed earnings per share of $2.65, beating the estimate of 80 cents. With 31.68K shares outstanding, the current market capitalization sits at 39.40B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IPKW59.020.53
+0.90%
Invesco Intl BuyBack Achiev™ ETF
EFAV89.960.46
+0.51%
iShares MSCI EAFE Min Vol Factor ETF
XBJL38.47-0.09
-0.23%
Innovator US Eq Acclrtd 9 Bffr ETF Jul
FLJJ32.20-0.12
-0.37%
AllianzIM US Equity 6M Flr 5 Jan/Jul ETF
SPBW27.54-0.11
-0.40%
AllianzIM Buffer20 Allocation ETF

ONC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
+0.40%
ZLAB - ONC
59%
Loosely correlated
+0.80%
ZYME - ONC
38%
Loosely correlated
+1.17%
AAPG - ONC
38%
Loosely correlated
+0.69%
WXXWY - ONC
37%
Loosely correlated
+1.97%
AXON - ONC
37%
Loosely correlated
-1.89%
More